288 related articles for article (PubMed ID: 9220600)
1. Effect of maternally acquired Aujeszky's disease (pseudorabies) virus-specific antibody in pigs on establishment of latency and seroconversion to differential glycoproteins after low dose challenge.
McCaw MB; Osorio FA; Wheeler J; Xu J; Erickson GA
Vet Microbiol; 1997 Apr; 55(1-4):91-8. PubMed ID: 9220600
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of serological tests for the detection of pseudorabies gE antibodies during early infection.
Kinker DR; Swenson SL; Wu LL; Zimmerman JJ
Vet Microbiol; 1997 Apr; 55(1-4):99-106. PubMed ID: 9220601
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the abilities of serologic tests to detect pseudorabies-infected pigs during the latent phase of infection.
White AK; Ciacci-Zanella J; Galeota J; Ele S; Osorio FA
Am J Vet Res; 1996 May; 57(5):608-11. PubMed ID: 8723868
[TBL] [Abstract][Full Text] [Related]
4. High- and low-challenge exposure doses used to compare intranasal and intramuscular administration of pseudorabies virus vaccine in passively immune pigs.
Arellano PE; Morrison RB; Molitor TW; Thawley DG
J Am Vet Med Assoc; 1992 Mar; 200(5):685-91. PubMed ID: 1314793
[TBL] [Abstract][Full Text] [Related]
5. Latent infection and subsequent reactivation of pseudorabies virus in swine exposed to pseudorabies virus while nursing immune dams.
Mengeling WL
Am J Vet Res; 1989 Oct; 50(10):1658-66. PubMed ID: 2552871
[TBL] [Abstract][Full Text] [Related]
6. Protection against pseudorabies virus infection by intranasal vaccination of newborn pigs.
McCaw MB; Xu J
Am J Vet Res; 1993 Apr; 54(4):527-33. PubMed ID: 8387249
[TBL] [Abstract][Full Text] [Related]
7. Sensitive glycoprotein gIII blocking ELISA to distinguish between pseudorabies (Aujeszky's disease)-infected and vaccinated pigs.
Kit M; Kit S
Vet Microbiol; 1991 Jul; 28(2):141-55. PubMed ID: 1651582
[TBL] [Abstract][Full Text] [Related]
8. Survival and immunization of raccoons after exposure to pseudorabies (Aujeszky's disease) virus gene-deleted vaccines.
Weigel RM; Hahn EC; Scherba G
Vet Microbiol; 2003 Mar; 92(1-2):19-24. PubMed ID: 12488067
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the pseudorabies virus-specific immunoglobulin M response and evaluation of its diagnostic use in pigs with preexisting immunity to the virus.
Kimman TG
J Clin Microbiol; 1993 Sep; 31(9):2309-14. PubMed ID: 8408547
[TBL] [Abstract][Full Text] [Related]
10. Detection of pseudorabies virus infection in subunit-vaccinated and nonvaccinated pigs using a nucleocapsid-based enzyme-linked immunosorbent assay.
McGinley MJ; Todd DL; Hill HT; Platt KB
J Vet Diagn Invest; 1992 Apr; 4(2):164-9. PubMed ID: 1319749
[TBL] [Abstract][Full Text] [Related]
11. Antibody titers to pseudorabies virus in piglets immunized with gIII deleted pseudorabies vaccine in a pseudorabies infected herd.
Elvinger F; Reeves DE; Pursell AR; Cole JR; Liauw H
Vet Microbiol; 1994 Dec; 42(4):341-8. PubMed ID: 9133059
[TBL] [Abstract][Full Text] [Related]
12. Blocking ELISA to distinguish pseudorabies virus-infected pigs from those vaccinated with a glycoprotein gIII deletion mutant.
Kit S; Awaya Y; Otsuka H; Kit M
J Vet Diagn Invest; 1990 Jan; 2(1):14-23. PubMed ID: 1965296
[TBL] [Abstract][Full Text] [Related]
13. Field trial to evaluate the immunogenicity of pseudorabies virus vaccines with deletions for glycoproteins G and E.
Firkins LD; Weigel RM; Biehl LG; Hahn EC
Am J Vet Res; 1997 Sep; 58(9):976-84. PubMed ID: 9285001
[TBL] [Abstract][Full Text] [Related]
14. The response of pigs inoculated with a thymidine kinase-negative (TK-) pseudorabies virus to challenge infection with virulent virus.
Ferrari M; Gualandi GL; Corradi A; Monaci C; Romanelli MG; Losio MN; Cantoni AM; Pratelli A
Comp Immunol Microbiol Infect Dis; 2000 Jan; 23(1):15-26. PubMed ID: 10660255
[TBL] [Abstract][Full Text] [Related]
15. Vaccine genotype and route of administration affect pseudorabies field virus latency load after challenge.
Vilnis A; Sussman MD; Thacker BJ; Senn M; Maes RK
Vet Microbiol; 1998 May; 62(2):81-96. PubMed ID: 9695282
[TBL] [Abstract][Full Text] [Related]
16. Intranasal vaccination of pigs against pseudorabies: absence of vaccinal virus latency and failure to prevent latency of virulent virus.
van Oirschot JT; Gielkens AL
Am J Vet Res; 1984 Oct; 45(10):2099-103. PubMed ID: 6093645
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of specific humoral immune response in pigs vaccinated intradermally with deleted Aujeszky's disease vaccine and challenged with virulent strain of Herpesvirus suis type 1.
Mikulska-Skupień E; Szweda W; Procajło Z
Pol J Vet Sci; 2005; 8(1):11-6. PubMed ID: 15794468
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity in Aujeszky's disease virus structural glycoprotein gVI (gp50) in swine.
Mukamoto M; Watanabe I; Kobayashi Y; Icatlo FC; Ishii H; Kodama Y
Vet Microbiol; 1991 Oct; 29(2):109-21. PubMed ID: 1660638
[TBL] [Abstract][Full Text] [Related]
19. Antibody response to glycoprotein I in maternally immune pigs exposed to a mildly virulent strain of pseudorabies virus.
van Oirschot JT; Daus F; Kimman TG; van Zaane D
Am J Vet Res; 1991 Nov; 52(11):1788-93. PubMed ID: 1664670
[TBL] [Abstract][Full Text] [Related]
20. Vaccination of pigs against pseudorabies with highly attenuated vaccinia (NYVAC) recombinant viruses.
Brockmeier SL; Lager KM; Tartaglia J; Riviere M; Paoletti E; Mengeling WL
Vet Microbiol; 1993 Dec; 38(1-2):41-58. PubMed ID: 8128602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
